Sarris, Jerome http://orcid.org/0000-0001-9287-8854
Murphy, Jenifer
Stough, Con
Mischoulon, David
Bousman, Chad
MacDonald, Patricia
Adams, Laura
Nazareth, Sonia
Oliver, Georgina
Cribb, Lachlan
Savage, Karen
Menon, Ranjit
Chamoli, Suneel
Berk, Michael
Ng, Chee H.
Byrne, Gerard J.
Funding for this research was provided by:
National Health and Medical Research Council (APP1048222)
Article History
Received: 27 May 2019
Accepted: 2 September 2019
First Online: 11 November 2019
Compliance with ethical standards
: The trial had ethics approval (TMC REC: 232; UQ MREC: 2014000702) and is registered with ANZCTR (protocol number: 12613001299796).
: JS has received honoraria, research support, royalties, or consultancy or travel grant funding from Integria Healthcare & MediHerb, Pfizer, Scius Health, Key Pharmaceuticals, Taki Mai, FIT-BioCeuticals, Blackmores, Soho-Flordis, Australian Natural Therapeutics Group, Grünbiotics, Healthworld, HealthEd, HealthMasters, SPRIM, Elsevier, Chaminade University, International Society for Affective Disorders, Complementary Medicines Australia, Terry White Chemists, ANS, Society for Medicinal Plant and Natural Product Research, Sanofi-Aventis, Omega-3 Centre, the National Health and Medical Research Council, and CR Roper Fellowship. DM has received research support from Nordic Naturals. He has received honoraria for consulting, speaking, and writing from the Massachusetts General Hospital Psychiatry Academy, Blackmores, and PeerPoint Medical Education Institute, LLC. He has provided unpaid consulting for Pharmavite LLC and Gnosis USA, Inc. He has received royalties from Lippincott Williams & Wilkins for published book ‘Natural Medications for Psychiatric Disorders: Considering the Alternatives.’ MB has received Grant/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Rotary Health, Geelong Medical Research Foundation, Bristol-Myers Squibb, Eli Lilly, Glaxo SmithKline, Meat and Livestock Board, Organon, Novartis, Mayne Pharma, Servier, Woolworths, Avant, and the Harry Windsor Foundation; has been a speaker for Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen-Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay, and Wyeth; and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Eli Lilly, Grunbiotics, Glaxo SmithKline, Janssen-Cilag, LivaNova, Lundbeck, Merck, Mylan, Otsuka, Pfizer, and Servier. CS has received research grants from Government: Australian Research Council; NHMRC; NDLERF; NIDA; VDLERF; ARC; Vicpolice; Vicroads; Nestle; SFI; Barry Callebaut; Blackmores; Flordis; Zeller; Clover Corporation; Horphag; GSK; Bayer; Pharmalink; Siemens; Securatek; Efamol; Cognis; Integria; Medvet, Cooper Nutrition, and paid strategic consulting advice for SFI, Blackmores, Bayer; ARU, Carlton FC, GSK India. DM has received research support from Nordic Naturals. He has provided unpaid consulting for Pharmavite LLC and Gnosis USA, Inc. He has received honoraria for speaking from the Massachusetts General Hospital Psychiatry Academy, from PeerPoint Medical Education Institute LLC, and from Blackmores. He has received royalties from Lippincott Williams & Wilkins for published book ‘Natural Medications for Psychiatric Disorders: Considering the Alternatives.’ GJB receives research support from Janssen-Cilag, Eli Lilly, Biogen, NHMRC (APP1104460, APP1095227, APP1063383, APP1048222) and the RBWH Foundation. He owns shares in CSL. He receives royalties from the sale of his books Community Mental Health for Older People and Psychosocial Dimensions of Medicine. He receives licensing fees from the use of his rating scale, the Geriatric Anxiety Inventory. He is employed by the University of Queensland, the Royal Brisbane & Women’s Hospital, and the Repatriation Medical Authority. CN had served as a consultant for Lundbeck, Grunbiotics, Servier, Janssen-Cilag, Wyeth and Eli Lilly, received research grant support from Wyeth and Lundbeck, and speaker honoraria from Servier, Lundbeck, Bristol-Myers Squibb, Organon, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Astra-Zenaca, Wyeth, and Pfizer.